![](https://scx1.b-cdn.net/csz/news/tmb/2018/5b3246e7cb52b.jpg)
Flu's response to new drug explored
The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018. Scientists from EMBL Grenoble have now investigated the drug's mode of action ...
Jun 26, 2018
0
10